Cargando…
Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome
BACKGROUND AND OBJECTIVES: Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are characterized by microangiopathic hemolytic anemia and thrombocytopenia. Interestingly, markedly different survival rates have been reported despite increases in survivability. We studied TTP...
Autores principales: | Bittencourt, Cassiana E., Ha, Jennifer P., Maitta, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441419/ https://www.ncbi.nlm.nih.gov/pubmed/26000799 http://dx.doi.org/10.1371/journal.pone.0127744 |
Ejemplares similares
-
Correction: Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome
por: Bittencourt, Cassiana E., et al.
Publicado: (2015) -
Clopidogrel-Induced Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome After Coronary Artery Stenting
por: Manor, Shawn M, et al.
Publicado: (2004) -
Post-Transfusion Simultaneous Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome: A Rare Occurrence
por: Patel, Maharshi, et al.
Publicado: (2022) -
Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancy
por: Mwita, Julius Chacha, et al.
Publicado: (2014) -
Anti‐CD20 therapeutic options in immune‐mediated thrombotic thrombocytopenic purpura
por: Maitta, Robert W.
Publicado: (2022)